EP2403833A4 - 8-substituted quinolines and related analogs as sirtuin modulators - Google Patents
8-substituted quinolines and related analogs as sirtuin modulatorsInfo
- Publication number
- EP2403833A4 EP2403833A4 EP10749227A EP10749227A EP2403833A4 EP 2403833 A4 EP2403833 A4 EP 2403833A4 EP 10749227 A EP10749227 A EP 10749227A EP 10749227 A EP10749227 A EP 10749227A EP 2403833 A4 EP2403833 A4 EP 2403833A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- related analogs
- substituted quinolines
- sirtuin modulators
- sirtuin
- modulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15674909P | 2009-03-02 | 2009-03-02 | |
PCT/US2010/025963 WO2010101949A1 (en) | 2009-03-02 | 2010-03-02 | 8-substituted quinolines and related analogs as sirtuin modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2403833A1 EP2403833A1 (en) | 2012-01-11 |
EP2403833A4 true EP2403833A4 (en) | 2012-08-29 |
Family
ID=42709991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10749227A Withdrawn EP2403833A4 (en) | 2009-03-02 | 2010-03-02 | 8-substituted quinolines and related analogs as sirtuin modulators |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2403833A4 (en) |
JP (1) | JP2012519211A (en) |
KR (1) | KR20110128908A (en) |
CN (1) | CN102414180A (en) |
AU (1) | AU2010221417A1 (en) |
BR (1) | BRPI1011477A2 (en) |
CA (1) | CA2754058A1 (en) |
EA (1) | EA201171098A1 (en) |
IL (1) | IL214943A0 (en) |
MX (1) | MX2011009213A (en) |
WO (1) | WO2010101949A1 (en) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8685970B2 (en) | 2008-05-01 | 2014-04-01 | GlaxoSmithKline, LLC | Quinolines and related analogs as sirtuin modulators |
BRPI0914006A2 (en) | 2008-07-03 | 2015-10-27 | Sirtris Pharmaceuticals Inc | benzimidazoles and related analogues as sirtuin modulators |
KR101679089B1 (en) | 2008-09-29 | 2016-11-23 | 서트리스 파마슈티컬즈, 인코포레이티드 | Chromenone analogs as sirtuin modulators |
KR20120092141A (en) | 2009-10-29 | 2012-08-20 | 서트리스 파마슈티컬즈, 인코포레이티드 | Bicyclic pyridines and analogs as sirtuin modulators |
CN103002738A (en) | 2010-05-21 | 2013-03-27 | 英特利凯恩有限责任公司 | Chemical compounds, compositions and methods for kinase modulation |
KR101834362B1 (en) | 2011-03-18 | 2018-03-05 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests |
CN102250151B (en) * | 2011-05-17 | 2013-11-06 | 中国科学院化学研究所 | 2-arimid-8-benzimidazol quinoline transition metal compound and preparation method and use thereof |
US8785470B2 (en) | 2011-08-29 | 2014-07-22 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
BR112014009518A2 (en) * | 2011-10-20 | 2017-04-25 | Glaxosmithkline Llc | Substituted bicyclic azaheterocycles and analogues as modulators of sirtuin |
EP2768509B1 (en) | 2011-10-20 | 2017-03-22 | Glaxosmithkline LLC | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
EA201491667A1 (en) | 2012-03-13 | 2015-03-31 | Басф Се | FUNGICIDE PYRIMIDINE COMPOUNDS |
AR093519A1 (en) | 2012-11-20 | 2015-06-10 | Hoffmann La Roche | 1,6-REPLACED NAFTIRIDINS |
DK2970272T3 (en) | 2013-03-14 | 2019-04-23 | Merck Patent Gmbh | glycosidase |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
US9776997B2 (en) | 2013-06-04 | 2017-10-03 | Bayer Pharma Aktiengesellschaft | 3-aryl-substituted imidazo[1,2-A]pyridines and their use |
TWI529171B (en) * | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | 1,7-naphthyridine derivatives |
CN105722833A (en) | 2013-09-16 | 2016-06-29 | 巴斯夫欧洲公司 | Fungicidal pyrimidine compounds |
WO2015036059A1 (en) | 2013-09-16 | 2015-03-19 | Basf Se | Fungicidal pyrimidine compounds |
US10172915B2 (en) | 2013-10-20 | 2019-01-08 | Duke University | Methods and compositions for activation of sirtuins with Annexin A1 peptides |
JP6112724B2 (en) * | 2013-10-31 | 2017-04-12 | 日本化薬株式会社 | 1,5-naphthyridine derivative and insecticide comprising the same as an active ingredient |
AU2014350371B2 (en) | 2013-11-12 | 2018-02-15 | F. Hoffmann-La Roche Ag | Pyrido[4,3-b]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders |
TW201612161A (en) | 2014-01-20 | 2016-04-01 | Bayer Cropscience Ag | Quinoline derivatives as insecticides and acaricides |
EP3107920B1 (en) | 2014-02-19 | 2017-10-18 | Bayer Pharma Aktiengesellschaft | 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines |
MX2016014483A (en) | 2014-05-23 | 2017-01-23 | Active Biotech Ab | Novel compounds useful as s100-inhibitors. |
US20160016951A1 (en) * | 2014-07-17 | 2016-01-21 | Merck Patent Gmbh | Novel naphthyridines and isoquinolines and their use as cdk8/19 inhibitors |
EP3174868B1 (en) | 2014-08-01 | 2021-08-25 | Nuevolution A/S | Compounds active towards bromodomains |
CN107108601B (en) | 2014-08-28 | 2021-08-20 | 阿森纽荣股份公司 | Glycosidase inhibitors |
CN107001361A (en) | 2014-12-02 | 2017-08-01 | 拜耳医药股份有限公司 | Imidazo [1,2 a] pyridine of heteroaryl substitution and application thereof |
CN104592109A (en) * | 2015-01-19 | 2015-05-06 | 湖南华腾制药有限公司 | Method for preparing 8-bromoquinoline derivative |
KR20170117479A (en) * | 2015-02-11 | 2017-10-23 | 바실리어 파마슈티카 인터내셔널 리미티드 | Substituted mono- and polyazanaphthalene derivatives and uses thereof |
BR112018017225A2 (en) | 2016-02-25 | 2019-01-15 | Asceneuron Sa | acid addition salt, compound, methods for preparing an acid addition salt, treating a tauopathy and inhibiting a glycosidase, and solid oral dosage form. |
CN108884077A (en) | 2016-02-25 | 2018-11-23 | 阿森纽荣股份公司 | Glycosidase inhibitor |
US11261183B2 (en) | 2016-02-25 | 2022-03-01 | Asceneuron Sa | Sulfoximine glycosidase inhibitors |
WO2017144639A1 (en) | 2016-02-25 | 2017-08-31 | Asceneuron S. A. | Glycosidase inhibitors |
US11213525B2 (en) | 2017-08-24 | 2022-01-04 | Asceneuron Sa | Linear glycosidase inhibitors |
US11731972B2 (en) | 2018-08-22 | 2023-08-22 | Asceneuron Sa | Spiro compounds as glycosidase inhibitors |
US11795165B2 (en) | 2018-08-22 | 2023-10-24 | Asceneuron Sa | Tetrahydro-benzoazepine glycosidase inhibitors |
WO2020176863A1 (en) * | 2019-02-28 | 2020-09-03 | Kezar Life Sciences | Thiazole derivatives as protein secretion inhibitors |
CN110964011B (en) * | 2019-12-16 | 2022-06-21 | 诚达药业股份有限公司 | Synthetic method of 8-chloro-1, 7-naphthyridine-3-formaldehyde |
US11753413B2 (en) | 2020-06-19 | 2023-09-12 | Incyte Corporation | Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors |
WO2021257857A1 (en) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Naphthyridinone compounds as jak2 v617f inhibitors |
US11767323B2 (en) | 2020-07-02 | 2023-09-26 | Incyte Corporation | Tricyclic pyridone compounds as JAK2 V617F inhibitors |
MX2023000056A (en) | 2020-07-02 | 2023-04-12 | Incyte Corp | Tricyclic urea compounds as jak2 v617f inhibitors. |
US11661422B2 (en) | 2020-08-27 | 2023-05-30 | Incyte Corporation | Tricyclic urea compounds as JAK2 V617F inhibitors |
US11919908B2 (en) | 2020-12-21 | 2024-03-05 | Incyte Corporation | Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors |
EP4298099A1 (en) | 2021-02-25 | 2024-01-03 | Incyte Corporation | Spirocyclic lactams as jak2 v617f inhibitors |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
CN117362286B (en) * | 2023-12-08 | 2024-03-12 | 清华大学 | Compounds with SIRT6 agonistic activity and uses thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999029318A1 (en) * | 1997-12-11 | 1999-06-17 | Biochem Pharma Inc. | Antiviral compounds |
WO2003037872A1 (en) * | 2001-11-01 | 2003-05-08 | Astrazeneca Ab | Therapeutic quinoline compounds with 5-ht-antagonistic properties |
WO2004080463A1 (en) * | 2003-03-10 | 2004-09-23 | Schering Corporation | Heterocyclic kinase inhibitors: methods of use and synthesis |
US20060183909A1 (en) * | 2001-07-20 | 2006-08-17 | Martine Schmitt | Compositions derived from quinoline and quinoxaline, preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007001267A (en) * | 2004-08-03 | 2007-07-11 | Serenex Inc | 2, 8-disubstituted naphthyridine derivatives. |
AU2006218405A1 (en) * | 2005-03-03 | 2006-09-08 | Sirtris Pharmaceuticals, Inc. | Acridine and quinoline derivatives as sirtuin modulators |
EP2250152A1 (en) * | 2008-02-28 | 2010-11-17 | Novartis AG | Quinolines as inhibitors of farnesyl pyrophosphate synthase |
US8685970B2 (en) * | 2008-05-01 | 2014-04-01 | GlaxoSmithKline, LLC | Quinolines and related analogs as sirtuin modulators |
KR101679089B1 (en) * | 2008-09-29 | 2016-11-23 | 서트리스 파마슈티컬즈, 인코포레이티드 | Chromenone analogs as sirtuin modulators |
-
2010
- 2010-03-02 AU AU2010221417A patent/AU2010221417A1/en not_active Abandoned
- 2010-03-02 WO PCT/US2010/025963 patent/WO2010101949A1/en active Application Filing
- 2010-03-02 CN CN2010800194505A patent/CN102414180A/en active Pending
- 2010-03-02 EA EA201171098A patent/EA201171098A1/en unknown
- 2010-03-02 CA CA2754058A patent/CA2754058A1/en not_active Abandoned
- 2010-03-02 MX MX2011009213A patent/MX2011009213A/en not_active Application Discontinuation
- 2010-03-02 EP EP10749227A patent/EP2403833A4/en not_active Withdrawn
- 2010-03-02 KR KR1020117023017A patent/KR20110128908A/en not_active Application Discontinuation
- 2010-03-02 BR BRPI1011477A patent/BRPI1011477A2/en not_active Application Discontinuation
- 2010-03-02 JP JP2011553053A patent/JP2012519211A/en not_active Withdrawn
-
2011
- 2011-09-01 IL IL214943A patent/IL214943A0/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999029318A1 (en) * | 1997-12-11 | 1999-06-17 | Biochem Pharma Inc. | Antiviral compounds |
US20060183909A1 (en) * | 2001-07-20 | 2006-08-17 | Martine Schmitt | Compositions derived from quinoline and quinoxaline, preparation and use thereof |
WO2003037872A1 (en) * | 2001-11-01 | 2003-05-08 | Astrazeneca Ab | Therapeutic quinoline compounds with 5-ht-antagonistic properties |
WO2004080463A1 (en) * | 2003-03-10 | 2004-09-23 | Schering Corporation | Heterocyclic kinase inhibitors: methods of use and synthesis |
Non-Patent Citations (1)
Title |
---|
See also references of WO2010101949A1 * |
Also Published As
Publication number | Publication date |
---|---|
MX2011009213A (en) | 2011-12-14 |
CN102414180A (en) | 2012-04-11 |
WO2010101949A1 (en) | 2010-09-10 |
AU2010221417A1 (en) | 2011-09-22 |
EA201171098A1 (en) | 2012-04-30 |
CA2754058A1 (en) | 2010-09-10 |
IL214943A0 (en) | 2011-11-30 |
EP2403833A1 (en) | 2012-01-11 |
BRPI1011477A2 (en) | 2016-03-22 |
KR20110128908A (en) | 2011-11-30 |
JP2012519211A (en) | 2012-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214943A0 (en) | 8-substituted quinolines and related analogs as sirtuin modulators | |
IL208997A0 (en) | Quinolines and related analogs as sirtuin modulators | |
IL219372A0 (en) | Bicyclic pyridines and analogs as sirtuin modulators | |
IL209567A0 (en) | Imidazopyridine and related analogs as sirtuin modulators | |
IL218770A0 (en) | Novel modulators | |
HK1178518A1 (en) | Novel benzopyran kinase modulators | |
AP2948A (en) | Thienopyrmidinedione derivatives as TRPA1 modulators | |
ZA201109535B (en) | Game system | |
IL210206A0 (en) | Benzimidazoles and related analogs as sirtuin modulators | |
EP2460425A4 (en) | Helmet | |
HK1166081A1 (en) | Isothiazolo-pyrimidinedione derivatives as trpa1 modulators | |
EP2350051A4 (en) | Pyridine, bicyclic pyridine and related analogs as sirtuin modulators | |
SG10201402723QA (en) | Flavonoid hydrogel | |
GB0909909D0 (en) | Microcapsules containing microrgnisms | |
PL2496340T3 (en) | Silica dispersion | |
GB0920846D0 (en) | Defenin inducing agent | |
EP2536693A4 (en) | Substituted 2-imidazolidones and analogs | |
GB0919414D0 (en) | Flame effect | |
AU328865S (en) | Nasal plug | |
GB0920540D0 (en) | Helmet | |
GB0918104D0 (en) | Helmet | |
HU3771U (en) | Jewellery for measuring vital parameters | |
TWM369905U (en) | Improved detachable hanging band | |
GB0902541D0 (en) | Methods to identify modulators | |
AU331514S (en) | Jewellery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110930 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA ME RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120731 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 35/02 20060101ALI20120725BHEP Ipc: A61K 31/4709 20060101ALI20120725BHEP Ipc: A61P 9/00 20060101ALI20120725BHEP Ipc: A61K 31/506 20060101ALI20120725BHEP Ipc: A61K 31/497 20060101ALI20120725BHEP Ipc: A61K 31/47 20060101ALI20120725BHEP Ipc: A61K 31/538 20060101ALI20120725BHEP Ipc: C07D 487/04 20060101ALI20120725BHEP Ipc: C07D 417/12 20060101ALI20120725BHEP Ipc: A61K 31/5377 20060101ALI20120725BHEP Ipc: A61P 3/00 20060101ALI20120725BHEP Ipc: A61K 31/501 20060101ALI20120725BHEP Ipc: C07D 401/14 20060101ALI20120725BHEP Ipc: C07D 215/48 20060101AFI20120725BHEP Ipc: A61P 5/50 20060101ALI20120725BHEP Ipc: A61K 31/4375 20060101ALI20120725BHEP Ipc: C07D 413/14 20060101ALI20120725BHEP Ipc: A61K 31/519 20060101ALI20120725BHEP Ipc: C07D 401/12 20060101ALI20120725BHEP Ipc: C07D 417/14 20060101ALI20120725BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130228 |